White House to announce drug pricing deal with Regeneron
Regeneron is the sole drugmaker among 17 large pharmaceutical companies that received letters from President Donald Trump.
Original Source
Read the full article at Newsnationnow →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.